{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:29:47Z","timestamp":1792009787383,"version":"4.4.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Swedish Cancer Institute"},{"name":"Swedish Cancer Institute"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>When drainage of complicated pleural space infections alone fails, there exists two strategies in surgery and dual agent-intrapleural fibrinolytic therapy; however, studies comparing these two management strategies are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine the outcomes of surgery versus fibrinolytic therapy as the primary management for complicated pleural space infections (CPSI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective review of adults with a CPSI managed with surgery or fibrinolytics between 1\/2015 and 3\/2018 within a multicenter, multistate hospital system was performed. Fibrinolytics was defined as any dose of dual-agent fibrinolytic therapy and standard fibrinolytics as 5\u20136 doses twice daily. Treatment failure was defined as persistent infection with a pleural collection requiring intervention. Crossover was defined by any fibrinolytics after surgery or surgery after fibrinolytics. Logistic regression with inverse probability of treatment weighting (IPTW) were employed to account for selection bias effect of management strategies in treatment failure and crossover.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 566 patients. Surgery was the initial strategy in 55% (311\/566). The surgery group had less additional treatments (surgery: 10% [32\/311] versus fibrinolytics: 39% [100\/255], P\u2009 &amp;lt;\u20090.001), treatment failures (surgery: 7% [22\/311] versus fibrinolytics: 29% [74\/255], P\u2009 &amp;lt;\u20090.001), and crossovers (surgery: 6% [20\/311] versus fibrinolytics: 19% [49\/255], P\u2009 &amp;lt;\u20090.001). Logistic regression analysis with IPTW demonstrated a lower odds of treatment failure with surgery compared with any fibrinolytics (odds ratio [OR], 0.20; 95% confidence interval [CI], 0.10\u20130.30; P\u2009&amp;lt;\u20090.001); and compared with standard fibrinolytics (OR, 0.20; 95% CI, 0.11\u20130.35; P\u2009&amp;lt;\u20090.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although there is a lack of consensus as to the optimal management strategy for patients with a CPSI, in surgical candidates, operative management may offer more benefits and could be considered early in the management course. However, our study is retrospective and nonrandomized; thus, prospective trials are needed to explore this further.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202108-964oc","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T15:04:32Z","timestamp":1657724672000},"page":"1827-1833","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":15,"title":["Comparing Initial Surgery versus Fibrinolytics for Pleural Space Infections: A Retrospective Multicenter Cohort Study"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3637-1802","authenticated-orcid":false,"given":"Candice L.","family":"Wilshire","sequence":"first","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anee S.","family":"Jackson","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin M.","family":"Meggyesy","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerrie E.","family":"Buehler","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ching","family":"Chang","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Analytics, Research and Data Science, Providence St. Joseph Health, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah C.","family":"Horslen","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua R.","family":"Rayburn","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carson C.","family":"Fuller","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander S.","family":"Farivar","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Bograd","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Louie","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Valli\u00e8res","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph W.","family":"Aye","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jed A.","family":"Gorden","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"key":"2026012203352410300_bib1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jtcvs.2006.09.038","article-title":"Management of pleural space infections: a population-based analysis","volume":"133","author":"Farjah","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026012203352410300_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/qjmed\/89.4.285","article-title":"The clinical course and management of thoracic empyema","volume":"89","author":"Ferguson","year":"1996","journal-title":"QJM"},{"key":"2026012203352410300_bib3","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/j.jtcvs.2017.01.030","article-title":"The American Association for Thoracic Surgery consensus guidelines for the management of empyema","volume":"153","author":"Shen","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026012203352410300_bib4","doi-asserted-by":"crossref","first-page":"ii41","DOI":"10.1136\/thx.2010.137000","article-title":"Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010","volume":"65","author":"Davies","year":"2010","journal-title":"Thorax"},{"key":"2026012203352410300_bib5","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1378\/chest.118.4.1158","article-title":"Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline","volume":"118","author":"Colice","year":"2000","journal-title":"Chest"},{"key":"2026012203352410300_bib6","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.suc.2014.08.004","article-title":"Surgical intervention for thoracic infections","volume":"94","author":"Raymond","year":"2014","journal-title":"Surg Clin North Am"},{"key":"2026012203352410300_bib7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa1012740","article-title":"Intrapleural use of tissue plasminogen activator and DNase in pleural infection","volume":"365","author":"Rahman","year":"2011","journal-title":"N Engl J Med"},{"key":"2026012203352410300_bib8","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S2213-2600(20)30533-6","article-title":"Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: a consensus statement","volume":"9","author":"Chaddha","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2026012203352410300_bib9","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.athoracsur.2010.05.014","article-title":"Systematic classification of morbidity and mortality after thoracic surgery","volume":"90","author":"Seely","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"2026012203352410300_bib10","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1378\/chest.13-1558","article-title":"A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection","volume":"145","author":"Rahman","year":"2014","journal-title":"Chest"},{"key":"2026012203352410300_bib11","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1016\/j.chest.2020.10.095","article-title":"Temporal trends in tunneled pleural catheter utilization in patients with malignancy: a multicenter review","volume":"159","author":"Wilshire","year":"2021","journal-title":"Chest"},{"key":"2026012203352410300_bib12","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1378\/chest.111.6.1548","article-title":"A randomized trial of empyema therapy","volume":"111","author":"Wait","year":"1997","journal-title":"Chest"},{"key":"2026012203352410300_bib13","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.athoracsur.2019.05.090","article-title":"Outcomes of operative and nonoperative treatment of thoracic empyema: A population-based study","volume":"108","author":"Nayak","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"2026012203352410300_bib14","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.athoracsur.2018.02.027","article-title":"Current state of empyema management","volume":"105","author":"Semenkovich","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"2026012203352410300_bib15","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1513\/AnnalsATS.201407-329OC","article-title":"Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery","volume":"11","author":"Piccolo","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203352410300_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000443334","article-title":"Management of intrapleural sepsis with once daily use of tissue plasminogen activator and deoxyribonuclease","volume":"91","author":"Mehta","year":"2016","journal-title":"Respiration"},{"key":"2026012203352410300_bib17","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1513\/AnnalsATS.201609-673OC","article-title":"Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The alteplase dose assessment for pleural infection therapy project","volume":"14","author":"Popowicz","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203352410300_bib18","first-page":"9796768","article-title":"Safety and efficacy of intrapleural tissue plasminogen activator and DNase during extended use in complicated pleural space infections","volume":"2016","author":"McClune","year":"2016","journal-title":"Can Respir J"},{"key":"2026012203352410300_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/MCP.0000000000000387","article-title":"Use of intrapleural tissue plasminogen activator and deoxyribonuclease in pleural space infections: an update on alternative regimens","volume":"23","author":"Gilbert","year":"2017","journal-title":"Curr Opin Pulm Med"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/19\/11\/1827\/66328779\/annalsats_19_11_1827.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/19\/11\/1827\/66328779\/annalsats_19_11_1827.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:38:40Z","timestamp":1769071120000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/19\/11\/1827\/8417834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":19,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,1]]},"published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202108-964oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11]]},"published":{"date-parts":[[2022,11,1]]},"assertion":[{"value":"2021-08-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}